Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rapport Therapeutics, Inc. | 6,280,525 | reported | 26 May 2026 | tx 9+7,520,667−64,817,983 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 May 2026 | SALE | Rapport Therapeutics, Inc. | 18,572 | 40.05 USD | 10b5-1 |
| 11 May 2026 | SALE | Rapport Therapeutics, Inc. | 133,618 | 40.24 USD | 10b5-1 |
| 07 May 2026 | SALE | Rapport Therapeutics, Inc. | 271,495 | 40.12 USD | 10b5-1 |
| 08 May 2026 | SALE | Rapport Therapeutics, Inc. | 5,018 | 40.31 USD | 10b5-1 |
| 10 Jun 2024 | CONVERSION | Rapport Therapeutics, Inc. | 6,551,449 | 0.00 USD | |
| 10 Jun 2024 | CONVERSION | Rapport Therapeutics, Inc. | 969,218 | 0.00 USD | |
| 10 Jun 2024 | CONVERSION | Rapport Therapeutics, Inc. | 298,103 | 0.00 USD | deriv |
| 10 Jun 2024 | CONVERSION | Rapport Therapeutics, Inc. | 8,000,000 | 0.00 USD | deriv |
| 10 Jun 2024 | CONVERSION | Rapport Therapeutics, Inc. | 56,091,177 | 0.00 USD | deriv |